CTSI Update

The Boston University Clinical and Translational Science Institute (BU CTSI) has received a five-year, $38.3 million grant renewal from the Clinical and Translational Science Award Program.The BU CTSI was established in 2008 and is one of more than 50 institutions comprising the national CTSA Consortium led by the National Center for Advancing Translational Sciences , part of the NIH. We provide tools, services, and resources to clinical investigators to maximize the impact of discoveries and speed the translation of research into improved patient care through collaborative approaches. Read Full Details

New Funding Opportunities

NOT-OD-20-107 Administrative Supplements to Existing NIH ECHO Cooperative Agreements Coronavirus Disease 2019 – related Research NOT-OD-20-112  Funding Opportunity Announcements for the RADx-UPInitiatives RFA-RM-20-020 NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) Office of The Director, National Institutes of Health ( OD ) NOT-CA-20-066 Funding Opportunity Announcement for Serological Sciences Centers of Excellence National Cancer Institute ( NCI ) RFA-HD-21-006 Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD )

Applications for Dermatological Research Through the Leo Foundation program, grants are awarded in support of research projects with potential to improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms, and address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved. .

The Maternal Health QuickFire Challenge The QuickFire challenge grants innovators up to $200,000 in support of ideas aimed at improving pregnancy, birth, and postpartum care for women, making birth safer in the United States and potentially changing the trajectory of health for a lifetime. In addition, awardees will receive access to the global JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.

News Highlights

Gathering Big Data to Accelerate the COVID-19 Fight The N3C aims to improve the efficiency and accessibility of analyses with COVID-19 clinical data, expand our ability to analyze and understand COVID, and demonstrate a novel approach for collaborative pandemic data sharing. Read More Researchers Can Join Forces with COVID-19 Collaboration Platform The   COVID-19 Collaboration Platform  (CovidCP) brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence. Read More

Collaborative Research Efforts NCATS and the CTSA Program Coordinating Centers have created a publicly accessible clinical research information platform with the aim of providing a centralized location of pre-clinicaltrials.gov investigational research studies. Read More

‌ ‌ ‌

Boston University Clinical & Translational Science Institute Accelerating Discoveries Towards Better Health  b u.edu/ctsi | ncats.nih.gov